It has become a good tradition for the Xstrahl team to participate in one of the largest events in the radiation oncology community; ASTRO. This year was not an exception and proved to be another fantastic event. We would like to say a big thank you to all our booth guests for making this event unforgettable.
We were glad to meet everyone at the always busy demonstrations of our state-of-the-art small animal radiation research platform, SARRP, together with its latest enhancements: the new imaging accessory, MuriFocus and our enhanced 3D imaging platform Muriglo. All our attendees had a chance to see SARRP in action and can now see why the SARRP will help find the biggest research discoveries and take them from bench to bedside.
RADiant, the first dual-modality surface radiation therapy system offering a non-surgical treatment alternative, was the focus of attention at the Xstrahl Medical booth. The new system offers a smart, simple and successful treatment, thanks to halo ring allowing for faster and more accurate treatments. We were also pleased to highlight our range of leading medical treatment systems, including the Xstrahl 200 system which offers superficial and orthovoltage treatments in a single device.
We were so pleased to see crowds at the presentations of our cutting-edge planning software Concerto 2.0 and XBeam. Concerto 2.0 is an upgrade to our clinical interface, designed to provide a comprehensive yet simple treatment workflow, while XBeam allows the user to calculate, run a protocol and export therapy plans for exposures on Xstrahl systems and beyond. Using these solutions is the easiest and best way to upgrade your planning process.
“It was great three days, full of meetings, talks, discussions, and demonstrations. It was a unique atmosphere and we met some great people — leading radiation therapy and research professionals with an eagerness to develop and innovate. At Xstrahl we believe the solutions we offer will help eradicate cancer, coupled with the devotion of radiotherapy professionals, researchers and radiation therapists throughout the world. Thank you for coming and spending this time with us.” Adrian Treverton, Xstrahl’s CEO.
